Download Files:
Products Details
Product Description
– Besifovir Dipivoxil maleate (LB80380 maleate) is an oral proagent of LB80317. Besifovir Dipivoxil maleate (LB80380 maleate) is effective in hepatitis B virus (HBV) DNA suppression for both treatment-naive and lamivudine-resistant chronic hepatitis B (CHB) patients in preliminary studies[1][2]</sup.
Web ID
– HY-19447A
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C26H38N5O12P
References
– [1]Yuen MF, et al. A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B. Antivir Ther. 2006;11(8):977-83.|[2]Lai CL, et al. Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut. 2014 Jun;63(6):996-1004.
CAS Number
– 441785-26-8
Molecular Weight
– 643.58
SMILES
– NC1=NC=C2N=CN(CC3(OCP(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)=O)CC3)C2=N1.O=C(O)/C=CC(O)=O
Clinical Information
– Phase 4
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
